ArticleJournal of inflammation research2025
Serum Cytokines as Predictive Biomarkers for Disease Severity in Pediatric Adenovirus Pneumonia.
Article in Journal of inflammation research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Inflammatory cytokines as biomarkers for disease severity in pediatric viral pneumonia: a systematic review and meta-analysis.Translational pediatrics · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: This study aimed to analyze the differential expression patterns of serum cytokines across severity-stratified pediatric adenovirus pneumonia cases and evaluate their clinical utility as predictive biomarkers for disease severity. Methods: This retrospective study included 88 pediatric adenovirus pneumonia cases and 54 healthy children between January 2021 and December 2024. Cases were stratified by disease severity into mild (n = 59) and severe (n = 29) pneumonia groups. We collected baseline clinical characteristics and measured pretreatment levels of 12 serum cytokines. Comparative analyses of cytokine profiles were performed across different severity groups (mild and severe) and healthy controls. The diagnostic performance of these cytokines for severe pneumonia detection was evaluated using receiver operating characteristic (ROC) curve analysis, with particular focus on the area under the curve (AUC) values. Results: Severe pneumonia cases exhibited a more pronounced clinical course, characterized by significantly longer hospitalization, fever duration, and cough persistence, a higher incidence of wheezing and tachypnea, and marked elevations in inflammatory markers (CRP, ESR, LDH, fibrinogen, D-dimer). Of the 12 cytokines elevated versus controls, only interleukin (IL)-6, IL-8, and IL-10 exhibited statistically significant, severity-dependent increases (p < 0.05) and were correlated with longer hospitalization and persistent cough. ROC analysis revealed IL-6 and IL-10 as superior predictors for disease severity, with AUC reaching 0.88 (95% CI: 0.83-0.94). At optimal cutoffs, IL-6 showed 93% sensitivity and 71% specificity, while IL-10 demonstrated 90% sensitivity and 83% specificity. IL-8 showed moderate diagnostic value (AUC = 0.79, with 69% sensitivity and 83% specificity). Conclusion: These findings demonstrate distinct cytokine expression patterns across varying severity levels of pediatric adenovirus pneumonia. The robust performance of IL-6 and IL-10 underscores their potential as biomarkers for early severity stratification in clinical practice.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.